Neoadjuvant Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Neoadjuvant Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma	pancreatic adenocarcinoma	Recruiting	Phase 2	2026-09-28		NCT05825066

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
National Cancer Institute (NCI)	3015
Wake Forest University Health Sciences	284

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Levine Cancer Institute	Charlotte	United States	110
Wake Forest Baptist Comprehensive Cancer Center	Winston-Salem	United States	26

Clinical trials